198 related articles for article (PubMed ID: 24997135)
1. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
Vieira T; Antoine M; Ruppert AM; Fallet V; Duruisseaux M; Giroux Leprieur E; Poulot V; Rabbe N; Sclick L; Beau-Faller M; Lacave R; Lavole A; Cadranel J; Wislez M
Lung Cancer; 2014 Aug; 85(2):276-81. PubMed ID: 24997135
[TBL] [Abstract][Full Text] [Related]
2. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract][Full Text] [Related]
3. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.
Pelosi G; Gasparini P; Cavazza A; Rossi G; Graziano P; Barbareschi M; Perrone F; Barberis M; Takagi M; Kunimura T; Yamada T; Nakatani Y; Pastorino U; Scanagatta P; Sozzi G; Garassino M; De Braud F; Papotti M
Lung Cancer; 2012 Sep; 77(3):507-14. PubMed ID: 22705117
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy.
Hsieh MS; Lin MW; Lee YH
Lung Cancer; 2019 Nov; 137():76-84. PubMed ID: 31561203
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Yvorel V; Patoir A; Casteillo F; Tissot C; Fournel P; Stachowicz ML; Karpathiou G; Tiffet O; Péoc'h M; Forest F
PLoS One; 2017; 12(7):e0180346. PubMed ID: 28671973
[TBL] [Abstract][Full Text] [Related]
8. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid carcinoma of the lung: a rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stages.
Roesel C; Terjung S; Weinreich G; Hager T; Chalvatzoulis E; Metzenmacher M; Welter S
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):407-413. PubMed ID: 28025310
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma.
Gu L; Xu Y; Chen Z; Pan Y; Lu S
Biomed Pharmacother; 2015 Dec; 76():134-40. PubMed ID: 26653560
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.
Terra SB; Jang JS; Bi L; Kipp BR; Jen J; Yi ES; Boland JM
Mod Pathol; 2016 Aug; 29(8):824-31. PubMed ID: 27174587
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.
Rossi G; Cavazza A; Sturm N; Migaldi M; Facciolongo N; Longo L; Maiorana A; Brambilla E
Am J Surg Pathol; 2003 Mar; 27(3):311-24. PubMed ID: 12604887
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
[TBL] [Abstract][Full Text] [Related]
15. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of pleomorphic carcinoma of the lung: diffuse ZEB1 expression predicts poor survival.
Miyahara S; Hamasaki M; Hamatake D; Yamashita S; Shiraishi T; Iwasaki A; Nabeshima K
Lung Cancer; 2015 Jan; 87(1):39-44. PubMed ID: 25479687
[TBL] [Abstract][Full Text] [Related]
17. Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies.
Forest F; Yvorel V; Karpathiou G; Stachowicz ML; Vergnon JM; Fournel P; Tiffet O; Trombert B; Péoc'h M
Hum Pathol; 2016 Mar; 49():99-106. PubMed ID: 26826416
[TBL] [Abstract][Full Text] [Related]
18. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
19. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
[TBL] [Abstract][Full Text] [Related]
20. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer.
Ko E; Lee BB; Kim Y; Lee EJ; Cho EY; Han J; Shim YM; Park J; Kim DH
Clin Cancer Res; 2013 Mar; 19(5):1204-12. PubMed ID: 23319821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
